/
/
/

Beryl Drugs Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)22.70
Volume (₹)1,394.00
High (₹)26.00
Upper Circuit29.98
Low (₹)22.70
Lower Circuit20.00
Prev Close24.99
52W High (₹)27.90
Price24.99
52W Low (₹)15.92

Share Market Cap & Key Ratios Overview

M.Cap (₹)12.67 Cr
Div. Yield (%)0.00
PE Ratio20.31
Debt to Equity0.43
Price to Book1.13
Book Value18.70
EPS (TTM)1.23
Face Value10.00
ROE (%)6.30

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
BERLDRG-XNSE
LTP
1W Low
1W High
Market cap (₹)
1776-2.25 (-0.13%)
1720.80
1809.65
4,25,150Cr
10036+321 (3.30%)
9866.35
10080.20
2,66,265Cr
4730+94.85 (2.05%)
4555
4730
1,76,301Cr
2306.1-85.9 (-3.59%)
2252.50
2442
1,25,352Cr
1190-54 (-4.34%)
1182.05
1266.15
1,23,591Cr
1372+21.8 (1.61%)
1337.30
1390.70
1,14,351Cr
1400.1+20.1 (1.46%)
1364.75
1400.60
1,12,474Cr
2533.15+44.4 (1.78%)
2457.35
2539
1,02,315Cr
1701.1+23.3 (1.39%)
1656.90
1724.50
97,757Cr
2015+6 (0.30%)
1989.10
2061.55
92,007Cr
24.99-0.61 (-2.38%)
22.25
27
13Cr

Key Highlights of Beryl Drugs Ltd Balance Sheet

Beryl Drugs Ltd balance sheet discloses shareholders' funds of ₹5.09Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹5.09Cr, and the reserves and surplus of the company is ₹4.41Cr.

The company has its non-current liabilities with total liabilities of ₹16.03Cr as of 2025-03-31.

The current liabilities are ₹4.38Cr as of 2025-03-31. At the same time, current assets are ₹9.13Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹6.01Cr, provided in the Beryl Drugs Ltd financial statements.